Ratings by Jefferies (Tycho Peterson)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/21/2026 | Agilent | A | Maintain | Hold (N/A) |
|
Details | ||
| 8/17/2026 | Freenome Inc. | FRNM | New Coverage | Buy (N/A) |
11.61 (12.72) |
9.56% | Details | |
| 8/6/2026 | Qiagen NV | QGEN | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2026 | Waters Corp. | WAT | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2026 | Mettler-Toledo | MTD | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2026 | Avantor Inc. | AVTR | Upgrade | Hold (Underperform) |
12.42 (17.29) |
39.21% | Details | |
| 7/23/2026 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2026 | Tempus AI Inc | TEM | Maintain | Underperform (Underperform) |
|
Details | ||
| 7/8/2026 | Agilent | A | New Coverage | Hold (N/A) |
131.14 (175.96) |
34.18% | Details | |
| 6/29/2026 | Quidel Corp. | QDEL | Maintain | Hold (N/A) |
|
Details | ||
| 5/29/2026 | Mesa Laboratories | MLAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2026 | Quidel Corp. | QDEL | Downgrade | Hold (Buy) |
11.66 (13.77) |
18.1% | Details | |
| 4/21/2026 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2026 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Tempus AI Inc | TEM | New Coverage | Underperform (N/A) |
44.16 (67.16) |
52.08% | Details | |
| 4/13/2026 | Veracyte, Inc | VCYT | New Coverage | Buy (N/A) |
31.35 (48.20) |
53.75% | Details | |
| 4/13/2026 | Caris Life Sciences Inc | CAI | New Coverage | Buy (N/A) |
19.20 (32.46) |
69.06% | Details | |
| 3/20/2026 | Mettler-Toledo | MTD | Upgrade | Buy (Hold) |
1191.54 (1669.62) |
40.12% | Details | |
| 3/18/2026 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2026 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2026 | Avantor Inc. | AVTR | Maintain | Underperform (N/A) |
|
Details | ||
| 2/10/2026 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2026 | Mettler-Toledo | MTD | Maintain | Hold (N/A) |
|
Details | ||
| 2/5/2026 | Qiagen NV | QGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2026 | Revvity Inc | RVTY | Maintain | Hold (N/A) |
|
Details | ||
| 12/17/2025 | Avantor Inc. | AVTR | Downgrade | Underperform (Hold) |
11.28 (12.42) |
10.11% | Details | |
| 12/16/2025 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2025 | Sera Prognostics Inc | SERA | New Coverage | Buy (N/A) |
3.40 (2.04) |
-40% | Details | |
| 12/1/2025 | BillionToOne Inc | BLLN | New Coverage | Hold (N/A) |
127.85 (111.47) |
-12.81% | Details | |
| 11/25/2025 | Agilent | A | Maintain | Hold (N/A) |
|
Details | ||
| 11/24/2025 | Exact Sciences | EXAS | Downgrade | Hold (Buy) |
100.67 (104.91) |
4.21% | Details | |
| 11/7/2025 | 10X Genomics | TXG | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2025 | Waters Corp. | WAT | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | Illumina | ILMN | Maintain | Hold (N/A) |
|
Details | ||
| 10/28/2025 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2025 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2025 | Agilent | A | Maintain | Hold (N/A) |
|
Details | ||
| 9/26/2025 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2025 | Waters Corp. | WAT | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2025 | Avantor Inc. | AVTR | Downgrade | Hold (Buy) |
13.44 (11.28) |
-16.07% | Details | |
| 8/1/2025 | Avantor Inc. | AVTR | Downgrade | Buy (Hold) |
13.44 (17.29) |
28.65% | Details | |
| 7/28/2025 | Revvity Inc | RVTY | Maintain | Hold (N/A) |
|
Details | ||
| 7/24/2025 | Laboratory Corporation of America | LH | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2025 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2025 | Pacific Biosciences of California | PACB | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2025 | GeneDx | WGS | Upgrade | Buy (Hold) |
57.34 (61.26) |
6.84% | Details | |
| 5/8/2025 | Quidel Corp. | QDEL | Upgrade | Buy (Hold) |
25.85 (11.66) |
-54.89% | Details | |
| 5/2/2025 | Hologic | HOLX | Maintain | Hold (N/A) |
|
Details | ||
| 2/18/2025 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2025 | Quidel Corp. | QDEL | Maintain | Hold (N/A) |
|
Details | ||
| 2/6/2025 | Laboratory Corporation of America | LH | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2025 | GeneDx | WGS | Maintain | Hold (N/A) |
|
Details | ||
| 1/31/2025 | Revvity Inc | RVTY | Maintain | Hold (N/A) |
|
Details | ||
| 1/30/2025 | Quest Diagnostics | DGX | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2025 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2024 | Quest Diagnostics | DGX | New Coverage | Buy (N/A) |
157.35 (242.95) |
54.4% | Details | |
| 12/10/2024 | Laboratory Corporation of America | LH | New Coverage | Buy (N/A) |
232.57 (329.90) |
41.85% | Details | |
| 12/10/2024 | Quidel Corp. | QDEL | New Coverage | Hold (N/A) |
38.20 (25.85) |
-32.33% | Details | |
| 12/10/2024 | Hologic | HOLX | New Coverage | Hold (N/A) |
75.34 (76.01) |
0.89% | Details | |
| 12/10/2024 | Qiagen NV | QGEN | New Coverage | Buy (N/A) |
43.42 (50.37) |
16.01% | Details | |
| 11/13/2024 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2024 | Waters Corp. | WAT | Upgrade | Buy (Hold) |
352.64 (455.98) |
29.3% | Details | |
| 10/8/2024 | Waters Corp. | WAT | Upgrade | Buy (Hold) |
352.51 (352.64) |
0.04% | Details | |
| 8/8/2024 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2024 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2024 | Revvity Inc | RVTY | Maintain | Hold (N/A) |
|
Details | ||
| 7/22/2024 | 10X Genomics | TXG | Upgrade | Buy (Hold) |
16.56 (72.96) |
340.58% | Details | |
| 6/3/2024 | Guardant Health | GH | New Coverage | Buy (N/A) |
27.47 (173.25) |
530.69% | Details | |
| 6/3/2024 | Natera | NTRA | New Coverage | Buy (N/A) |
110.12 (404.90) |
267.69% | Details | |
| 6/3/2024 | 10X Genomics | TXG | New Coverage | Hold (N/A) |
22.41 (16.56) |
-26.1% | Details | |
| 6/3/2024 | Pacific Biosciences of California | PACB | New Coverage | Buy (N/A) |
1.94 (2.25) |
15.98% | Details | |
| 6/3/2024 | Illumina | ILMN | New Coverage | Hold (N/A) |
101.05 (271.04) |
168.22% | Details |
